Financial Information

Tax Information Letter    Form 10 Information Statement

Myriad Genetics, Inc.'s latest financial information is provided below. We are a July 1 to June 30 fiscal year company.

Latest Earnings Release and 10-Q Date Filed Format Size  
Second Quarter Financial Results HTML file N/A  
Form 10-Q Feb 5, 2014 HTML file  PDF file   View XBRL 284.7 KB Add to Briefcase
Form 10-Q Nov 12, 2013 HTML file  PDF file   View XBRL 257.9 KB Add to Briefcase
 
Latest Annual Report and 10-K Date Filed Format Size  
Annual Report 2013   PDF 4.9 MB Add to Briefcase
Form 10-K Aug 14, 2013 HTML file  PDF file   View XBRL 915.7 KB Add to Briefcase
 
Latest Proxy Statement Date Filed Format Size  
Proxy Statement (DEFR14A) Nov 27, 2013 HTML file  PDF file 29.9 KB Add to Briefcase
Proxy Statement (DEFA14A) Oct 15, 2013 HTML file  PDF file 40.7 KB Add to Briefcase
Proxy Statement Oct 15, 2013 HTML file  PDF file 790.3 KB Add to Briefcase

Add to Briefcase = add PDF file to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
37.97
Change:
- 0.36
Open:
38.41
Previous Close:
38.33
Day High:
38.98
Day Low:
37.62
52 Week High:
42.50
52 Week Low:
20.02
Volume:
2,031,300
4:00 PM ET on Apr 17, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com